This inventor holds 1 USPTO granted patent. Top assignee: Kanaph Therapeutics Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Sungpil Choi
Introduction
Sungpil Choi is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on SHP2 inhibitors. His research focuses on developing solutions for diseases related to SHP2, showcasing his commitment to advancing medical science.
Latest Patents
Sungpil Choi holds a patent for an SHP2 inhibitor and its use. The patent describes a pharmaceutical composition aimed at preventing or treating diseases associated with SHP2. This invention is crucial as it offers a method for effectively addressing health issues linked to this protein.
Career Highlights
Choi is currently associated with Kanaph Therapeutics Inc., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a dedication to finding innovative solutions that can lead to better health outcomes.
Collaborations
Some of his notable coworkers include Miyeon Kim and Dohyun Park, who contribute to the collaborative efforts at Kanaph Therapeutics Inc. Together, they work towards advancing the understanding and treatment of diseases related to SHP2.
Conclusion
Sungpil Choi's contributions to the field of pharmaceuticals through his patent on SHP2 inhibitors highlight his role as an influential inventor. His work not only reflects his expertise but also his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile